Take 5 Holds Its Ground, but the Earnings Recovery Loses Headroom
Key Takeaways
- Take 5 met the demand test behind our Q1 upgrade: its 3.6% comp matched the expected mid-3% range, lower-income softness did not widen, and 50 new shops extended the growth runway. A roughly 70bp margin decline shows that resilient sales are providing less earnings protection.
- The unchanged $430–460M EBITDA range masks a weaker outlook: management now expects the low end. Restatement costs are heading toward $45M, and a separate $4M accounting cleanup in glass challenges last quarter's view that the reporting overhang was easing.
- Free cash flow of $44.7M and 3.1x net leverage keep the 3.0x year-end objective credible. Shareholder returns remain a choice to be announced after the threshold is reached; the rejected conditional acquisition proposal does not establish a realizable value floor.
- Rating: Downgrading to Hold from Outperform. Our $13.50 base value offers 4.2% upside from the $12.96 reaction close. Take 5 remains investable, but lower earnings headroom and unresolved controls no longer support underwriting substantial discount compression.
Results vs. Consensus
| Q2 2026 metric | Actual | Consensus | Result | Magnitude |
|---|---|---|---|---|
| Revenue | $507.4M | $506.3–507.7M | In line | −0.1% to +0.2% |
| Adjusted diluted EPS, continuing operations | $0.29 | $0.26–0.27 | Beat | +$0.02–0.03 |
Quality of Beat/Miss
The operating business cleared a modest quarterly hurdle, but the annual earnings cushion shrank. Adjusted EBITDA fell 6.9% to $107.0M; removing $11.8M of restatement expense lifts growth to 3.4%, still slower than revenue. The separate glass cleanup accounts for another $4M of expense and further complicates the recovery.
Year-over-year comparisons
| Metric | Q2 2026 | Q2 2025, restated/recast | YoY change |
|---|---|---|---|
| Revenue | $507.4M | $475.2M | +6.8% |
| Operating income | $73.1M | $47.0M | +55.3% |
| Net income, continuing operations | $37.3M | $16.4M | +126.8% |
| GAAP diluted EPS, continuing operations | $0.23 | $0.10 | +130.0% |
| Adjusted EBITDA | $107.0M | $115.0M | −6.9% |
| Adjusted EBITDA margin | 21.1% | 24.2% | −310bp |
| Adjusted diluted EPS, continuing operations | $0.29 | $0.30 | −3.3% |
Quarter-over-quarter comparisons
| Metric | Q2 2026 | Q1 2026 | QoQ change |
|---|---|---|---|
| Revenue | $507.4M | $484.4M | +4.7% |
| Operating income | $73.1M | $67.4M | +8.3% |
| Net income, continuing operations | $37.3M | $23.8M | +56.4% |
| Adjusted EBITDA | $107.0M | $104.1M | +2.8% |
| Adjusted EBITDA margin | 21.1% | 21.5% | −40bp |
| Adjusted diluted EPS, continuing operations | $0.29 | $0.30 | −3.3% |
Revenue: Growth of 6.8% came with positive comps across all three segments and a larger Take 5 footprint. The 3.6% Take 5 comp is a slowdown from Q1's 4.5%, but it is the slowdown management had already forecast. Treating that deceleration alone as a new demand failure would miss the central test: management again says the weakness remains concentrated in lower-income customers. New locations continue to expand revenue even while established-shop growth moderates.
Margins: Excluding restatement costs, EBITDA was approximately $118.8M and the margin 23.4%, still below the comparable 24.2%. Adding back the separate glass charge would put EBITDA near $122.8M and the margin near 24.2%. That bridge explains most of the consolidated compression, but it does not erase Take 5's own operating-cost pressure. Last quarter's improving underlying margin has become a roughly flat consolidated outcome only after both adjustments.
EPS: The adjusted EPS beat is more modest than the GAAP improvement suggests. Interest expense fell $10.4M to $20.8M, helping absorb weaker EBITDA, yet adjusted net income still slipped to $48.2M from $48.9M. GAAP operating profit also benefits from lapping substantial prior-year impairment and related charges. Adjusted EPS excludes items including stock compensation and acquired-intangible amortization, while retaining restatement expense and the glass cleanup. The economics therefore require separating debt savings from repeatable operating improvement.
Segment Performance
| Segment | Revenue | Same-store sales | Adjusted EBITDA | EBITDA margin |
|---|---|---|---|---|
| Take 5 | $334.8M | +3.6% | $114.9M | 34.3% |
| Franchise Brands | $69.6M | +0.5% | $41.2M | 59.1% |
| Auto Glass Now | $72.9M | +2.6% | $3.5M | 4.8% |
| Corporate and Other | $30.1M | n/a | ($52.5M) | n/a |
| Consolidated | $507.4M | +1.4% | $107.0M | 21.1% |
Segment dollars are rounded; totals reflect consolidated results. Margins use segment revenue. Car wash operations are excluded from continuing-operation comparisons.
Take 5: the core growth pillar holds, with less margin help
Take 5 generated $114.9M of EBITDA, up 7.8%, as its system sales rose 13.2% and its footprint reached 1,421 shops. The 24th consecutive positive comp supports the durable-service proposition, and the 10.2% two-year comp stack makes this quarter's moderation less alarming. However, store inflation reduced margin by about 70bp year over year. Footprint and sales growth are still producing incremental profit, but they no longer carry Q1's margin-expansion tailwind.
Assessment: We keep the Take 5 engine on track and retain a roughly 34% segment-margin assumption. That supports continued investment in shops, while the weaker cost conversion argues against raising the consolidated earnings estimate merely because the comp streak continues.
Franchise Brands: moderation was expected; cash generation remains useful
Comps slowed to 0.5% from 0.9% in Q1, consistent with the prior warning that collision would stabilize rather than rebound. Meineke remained strong, while discretionary Maaco demand stayed soft. EBITDA fell $2.4M to $41.2M as technology and personnel spending weighed; revenue also reflects the sale of two company-operated collision locations. The 59.1% margin remains close to the roughly 60% level that underwrites this segment's funding role.
Assessment: The franchise-drag risk stays contained. Modest top-line growth is sufficient if margins remain near 60%; a broad collision rebound is unnecessary to our base case. Further spending that pushes margins persistently below that framework would be more consequential than a flat comp.
Auto Glass Now: a cleanup charge reveals more than a weak quarter
Glass comps slowed to 2.6%, while EBITDA fell from $10.1M to $3.5M. The roughly $4M out-of-period charge relates to balance-sheet cleanup from 2024 and earlier. Removing it lifts quarterly EBITDA to about $7.5M, or a 10.3% margin, which fits management's low-double-digit baseline. Even then, profit remains about $2.6M below the prior year. The charge explains most, but not all, of the decline.
Assessment: Glass remains a longer-term option rather than the near-term earnings engine. A restored low-double-digit margin would be progress, but a fresh historical accounting expense after the restatement raises the risk premium for the entire company. We do not assume an immediate return to last year's glass profit.
Key KPIs
| KPI | Q2 2026 | Q1 2026 / prior expectation | Investment read |
|---|---|---|---|
| Take 5 same-store sales | 3.6% | 4.5%; Q2 expected mid-3% | Met the demand signpost |
| Take 5 shops | 1,421 | 1,371 at Q1 end | 50 net additions; 24 franchised |
| Take 5 pipeline | About 800 | 150+ annual openings commitment | More than one-third site secured or beyond |
| Non-oil services / Take 5 sales | Almost 30% | Rising attachment was a thesis pillar | Further wallet-share contribution |
| Premium mix / attachment | Low 90s / high 50s | Rising in Q1 | Supports check; traffic split still absent |
| Net leverage | 3.1x | 3.2x; target 3.0x by year-end | Closer, with allocation decision pending |
| Quarterly free cash flow | $44.7M | $30.3M in Q1 | H1 approximately $75.0M |
| Restatement expense | $11.8M | Q2 expected above $15M | About $3M shifts into Q3 |
Free cash flow includes discontinued operations and deducts capital expenditure net of sale-leaseback proceeds. Q2 net capex fell $11.7M year over year to $31.0M, accounting for most of the $13.2M FCF improvement. This is useful cash for deleveraging, but it is not evidence of an equivalent surge in continuing-business operating cash generation.
Key Topics & Management Commentary
Overall Management Tone: Management remained confident in Take 5's demand resilience but was more cautious on earnings than in Q1. The low-end outlook and emphasis on financial discipline tempered last quarter's confidence in a clearing overhang; the capital-return discussion also became more explicit about the prerequisite of reaching 3.0x.
1. Stable customer cohorts do not eliminate the pricing trade-off
"So generally speaking, what I would say is that lower income consumer continues to be moderating, so to speak, but it has stabilized, and we see strength with the rest of our consumer base."
— Danny Rivera, President and CEO
This answers the primary demand question carried from Q1: management is not describing spreading weakness. Higher oil costs nevertheless create a new tension. Corporate shops took some price late in Q2, and further cost increases may require more pricing in the second half. A customer can remain willing to buy essential oil changes while becoming more selective about provider or promotion, so stable cohorts today do not make future price increases costless.
Assessment: The previously stated traffic-based downgrade trigger has not fired. Our more cautious rating instead reflects lower profit headroom: targeted promotions may defend customer acquisition, but the company has not shown a quantified retention improvement that would offset further cost inflation.
2. The shop pipeline makes growth investable, not automatic
"Our new unit pipeline remains robust at approximately 800 locations, more than 1/3 of which are site secured or further along. And we remain committed to opening 150 or more units annually as we progress toward our long-term goal of more than 2,500 total locations."
— Danny Rivera, President and CEO
Fifty openings in a quarter, almost half franchised, show that the development engine is functioning. The gap from 1,421 shops to more than 2,500 offers years of expansion, but roughly two-thirds of the pipeline is not yet described as site secured. The relevant underwriting question is the pace at which mature-shop cash and franchise capital can fund new stores while preserving their returns.
Assessment: We continue to assume at least 150 annual openings for Take 5, consistent with the stated commitment, without extrapolating this quarter into a guaranteed 200-store year. Store growth keeps the earnings recovery plausible even if comps stay in the low-to-mid single digits.
3. Attachment is now a meaningful business within the oil-change visit
"Our Net Promoter Scores remain in the mid-70s, and we continue to see meaningful contribution from our non-oil change services, which represented almost 30% of Take 5 sales for the quarter."
— Danny Rivera, President and CEO
Nearly 30% of sales from non-oil services demonstrates why the attachment pillar matters: an established customer visit can carry additional revenue without requiring another shop or an entirely new customer acquisition. Differential service broadens that opportunity. At premium oil mix already in the low 90s, however, the remaining mix runway is narrower than the shop-development runway.
Assessment: We retain attachment as a distinct earnings lever, with service breadth and repeat visits doing more work than further premium-oil penetration. A meaningful reversal in attachment would undermine the check growth currently helping to offset weaker lower-income traffic.
4. Lower Q2 restatement spending was a delay, not a saving
"Restatement costs were approximately $3 million below our initial Q2 expectations. We expect those costs to shift into Q3 as we complete our audit work on our whole business securitization financials. Year-to-date restatement costs totaled $20.9 million."
— Michael Diamond, CFO
Last quarter's recap treated below-plan spending as part of an easing overhang. This quarter offers less support for that interpretation: annual costs are now expected near $45M, and roughly $24.1M would still be incurred in the second half. Returning to the normal reporting cadence is progress, but the $4M glass cleanup shows that completing filings and eliminating accounting surprises are different milestones.
Assessment: We move the restatement/controls risk back to materializing. Our 2027 earnings recovery assumes only $30M of the roughly $45M annual expense disappears, leaving a $15M residual cost allowance. Full and prompt elimination remains an upside case.
5. Deleveraging is nearly complete; the distribution decision is not
At 3.1x leverage and approximately $75M of first-half free cash flow, the year-end debt objective remains credible. The CFO said the company would explain its capital-allocation execution plan when it reaches the actual 3.0x number. That condition is a useful correction to the prior recap's characterization of deleveraging as effectively done. Capital could fund more Take 5 shops, shareholder returns, or a mix; this call did not allocate dollars among them.
Assessment: The balance-sheet pillar remains on track, but an unannounced distribution cannot support EPS accretion or dividend yield in the base case. The catalyst becomes stronger when the company reaches 3.0x and specifies the size, form and timing of the allocation.
6. Rejecting the acquisition proposal raises the standalone execution burden
The board rejected ADW Capital's non-binding $18-per-share proposal on August 3, calling it highly conditional and inadequate relative to long-term value. The call defended the standalone plan through Take 5 growth, franchise cash, disciplined capital allocation and reliable execution. Those are measurable operating objectives, but the company offered no numerical valuation bridge for rejecting the proposal.
"And then I'd say the third thing is no surprises. We have to execute flawlessly, and we have to put our heads down and just do what we say we're going to do."
— Danny Rivera, President and CEO
Assessment: The proposal is evidence of strategic interest, not a completed transaction or a floor under the stock. After a new accounting charge, the board's confidence deserves less valuation weight than actual cash deployment and dependable earnings. Our base value is derived from standalone earnings, with no acquisition premium.
Guidance & Outlook
| FY2026 metric | Prior range / posture | New range / posture | Change |
|---|---|---|---|
| Revenue | $1.95–2.05B | $1.95–2.05B | Range maintained |
| Adjusted EBITDA | $430–460M | $430–460M; low end expected | Range maintained; outlook weaker |
| Adjusted diluted EPS | $1.15–1.25 | $1.15–1.25 | Range maintained |
| Restatement costs | $35–45M | Near $45M | High end now expected |
| Same-store sales | Flat to +2% | Flat to +2% | Maintained |
| Net store growth | 160–190 | 160–190 | Maintained |
| Free cash flow | $125–145M | $125–145M | Maintained |
| Net leverage at year-end | 3.0x | 3.0x | Maintained |
The required second half: First-half revenue of $991.9M leaves $958.1–1,058.1M to meet the annual range. First-half EBITDA of $211.1M leaves $218.9–248.9M; the low-end outcome requires only 3.7% more EBITDA in H2 than H1. That is achievable with continued shop openings and stable comps, but the approximately $24.1M of remaining restatement spending means the second half does not receive the clean cost roll-off previously anticipated.
The EPS range requires about $0.56–0.66 in the second half after $0.59 in H1. We use $1.15 for FY26, the low end of the maintained EPS range, because low-end EBITDA and higher cleanup costs leave little reason to retain the prior $1.20 midpoint anchor. That is a 4.2% reduction in the valuation earnings assumption, while our revenue estimate remains $2.0B.
Guidance style: The formal ranges preserve flexibility, but the low-end emphasis conveys an estimate reduction. Q2 Take 5 comps delivered the prior expectation; the disappointment is how little operating and remediation-cost cushion remains. Calling the entire outlook unchanged would obscure the information most relevant to earnings.
Analyst Q&A Highlights
Oil inflation: protecting dollars can still dilute the rate
The exchange tested whether the pricing response is intended to preserve gross profit dollars or the margin percentage, an important distinction after Take 5's margin decline.
Q: "Is the goal to manage the gross margin dollars or gross margin rate?"
— Tristan Thomas-Martin, BMO
A: "Yes. In the short term, what we try to do is manage to gross margin dollars. And that's our way of kind of making sure that we protect both the P&L as much as humanly possible, but also protecting value that we're delivering to the consumer."
— Danny Rivera, President and CEO
Assessment: The answer accepts near-term rate dilution to preserve dollar profit and customer value. Management separately describes possible long-run expansion if costs recede while prices hold; that is conditional upside, not a promised second-half margin recovery.
Store expenses: broad inflation, with no extra price action yet
The follow-up distinguished oil pass-through from other shop expenses and asked whether the latter required additional pricing.
Q: "And then the comment on the inflation and store expenses. What's that related to? Is that a temporal or permanent change? And then does that necessitate further pricing action on your part going forward?"
— Simeon Gutman, Morgan Stanley
A: "I would say I'd start off with it's not one specific thing. This is, quite frankly, a little bit of increase across several of the various line items that, when you put it all together, is store expenses. I don't see the need at the moment to take additional price to offset this."
— Michael Diamond, CFO
Assessment: The response explains the breadth of the pressure but does not establish that it is temporary. Continued confidence in a mid-30s segment margin supports our roughly 34% assumption; it does not support extrapolating Q1's rate expansion.
Glass cleanup: nonrecurring does not mean economically irrelevant
Questioning sought to distinguish seasonality from a one-off charge in the weak glass margin.
Q: "Just switching to the Auto Glass Now. EBITDA margin for the quarter was a bit lower than we would have expected. Is there anything to do with seasonality or one-offs in the figure there?"
— Mark Jordan, Goldman Sachs
A: "Yes. As we called out in the prepared remarks, it's largely driven by the one-off we took. So we took roughly $4 million of an out-of-period expense that relates to some balance sheet cleanup from 2024 and prior. We hit it this quarter. We called it out because it's significant to the segment and wanted to make sure that people understand we don't view the $3.5 million number as the run rate earnings power of the business in Q2."
— Michael Diamond, CFO
Assessment: The explanation supports adjusting the run rate upward, but it also establishes the historical-accounting nature of the charge. Our approximate $7.5M ex-charge result remains below the $10.1M prior-year quarter. Treating the entire shortfall as a one-off would overstate the operating recovery.
Capital allocation: the milestone precedes the commitment
The question pressed for shareholder-friendly action as leverage approaches the target. The answer put the debt milestone ahead of any allocation announcement.
Q: "I mean you're at 3.1x levered, target 3, obviously, steadily approaching that target. Can you just give us some insight on if and how capital allocation kind of priorities change in a delevered environment? Are you considering shareholder-friendly actions, buybacks, strategic transactions or other value-enhancing alternatives?"
— Michael Albanese, Benchmark
A: "There's a lot of different levers we could pull. Some of them could be additional investment in the business as we think about the great 4-wall economics that a Take 5 box look at. Some of them could be return of capital. We're working in partnership with our Board and the rest of management to identify what those strategies can and should be. And as we get to the actual 3x number, we'll be prepared to talk about not only the thoughts, but how we plan to execute that going forward."
— Michael Diamond, CFO
Assessment: The response presents alternatives rather than authorization. Take 5 reinvestment may be a better use of cash than a distribution, but until a plan is disclosed, the prior shareholder-return catalyst remains optionality rather than an estimate input.
Glass growth: contract wins make the path uneven
The exchange asked for a comp and margin framework for the newly separated glass segment. Management described how contract wins can change the growth rate without providing an annual comp target.
Q: "So now that you're breaking out the Glass business, I guess, how should we think about comps for that business? I understood it could be very choppy. But when we think about -- I guess, should we think about some sort of annual target average over the next few years. Similar -- then similar question on the segment's margin structure. How should we think about the evolution there?"
— Phillip Blee, William Blair
A: "We do not view that growth as linear. As you win new contracts, you could see step changes. But in between those contracts, the goal is just to continue executing against our existing customer base and continuing to find operational efficiencies. […] From a margin perspective, I think what you've seen so far, which is kind of a low double-digit margin from where we stand today is probably the right baseline from which to grow. The good news is, as we add additional traffic, the marginal flow-through is better than that. And so as we add additional sales, either through continued operational improvement or through new customers, we should be able to continue growing that business from both a dollars and a margin perspective. But I wouldn't get over anchored on that, as we've talked in the past, again, this is an incubation. It is part of the growth strategy, but more of the longer-term growth strategy. The near-term growth and the near-term margin, quite frankly, will be driven by our ability to continue growing Take 5 and the continued near 60% margins of the Franchise Brands business."
— Michael Diamond, CFO
Assessment: This is a plausible explanation for volatility, not a quantified contract pipeline. We allow glass to recover toward a low-double-digit margin after the charge, but assign most near-term operating growth to Take 5 rather than forecast a speculative step-up in insurance contracts.
Targeted promotions: a retention tool, with no measured lift disclosed
The exchange tested whether the response to lower-income softness represented a broader change in Take 5's pricing and promotional approach. Management described the quarter's elevated promotional activity as normal seasonal behavior, with no unusual change to call out, before explaining its selective approach to value-sensitive customers.
Q: "And then just in terms of Take 5's pricing and promo strategy, have there been any changes there? And then just more broadly, how did promos trend in Q2 relative to prior quarters, both for Driven and the industry?"
— Sarah Morin, Piper Sandler
A: "We are not a promotional brand as a foundational matter, but it's something that where and when it makes sense, we deploy it. If I relate it back to that lower income consumer and the moderation that we're seeing, that tends to be a solution that using that tool of promotions makes sense. It is a readily identifiable group of customers that are motivated by value. So that makes sense for us to maybe be surgical in terms of how we think about promotions, targeting those groups and trying to drive top of the funnel activity."
— Danny Rivera, President and CEO
Assessment: The answer preserves premium positioning and identifies a sensible acquisition tactic. It supplies no incremental retention, visit or return-on-marketing measure, so the shared CRM platform and selective promotions do not yet justify a higher comp forecast.
What They're NOT Saying
- A complete control-remediation date: Filing compliance has been restored, but there is no dated finish line for the material-weakness work. The distinction matters to how much of the roughly $45M cost burden can disappear in 2027.
- Traffic versus ticket, and the size of the affected cohort: Stable lower-income trends and rising check are useful, but the absence of a traffic decomposition limits our ability to distinguish retention success from pricing and mix.
- A quantified marketing payoff: Management describes first-party data and oil-change reminders without acquisition-cost or incremental-visit results. The capability is relevant to the problem; its contribution to a recovery is not yet measured.
- A concrete distribution or standalone value bridge: Neither an authorized return of capital nor a numerical explanation for the rejected proposal was provided. Long-term shop targets help assess growth, but do not by themselves establish a realizable equity value.
Market Reaction
- Pre-print setup: The August 5 close was $14.61, down 1.4% year to date, 3.4% over the prior 30 days and 15.9% over 12 months. The pre-print 52-week closing range was $10.30–19.21; the S&P 500 had gained 12.8% year to date.
- August 6 reaction session: The stock opened at $14.30, traded between $12.90 and $14.30, and closed at $12.96, down 11.3%. Volume was approximately 1.2M shares, 1.4x the preceding 30-day average, while the S&P 500 fell 0.2%.
In our view, the sharp underperformance is more consistent with a reduced earnings cushion and renewed accounting uncertainty than with a failure of the guided Take 5 comp. The stock entered the print already lagging the market, so this was not simply a richly valued growth business meeting expectations. An annual EBITDA outcome near the low end, coupled with a fresh cleanup charge, challenges the timing of the expected recovery.
The lower share price absorbs some of that deterioration. It also removes the argument that last quarter's Outperform can be carried forward solely because the core customer held up. The return case now depends on both better earnings and a willingness to pay more for them; the current accounting and capital-allocation evidence supports a more restrained multiple.
Street Perspective
Debate: healthy franchise engine or declining earnings quality?
Bull view: Positive comps, 50 Take 5 openings and continuing debt reduction indicate that the growth-and-cash model is functioning. Much of the profit pressure has identifiable nonrecurring causes.
Bear view: Repeated adjustments and a low-end annual outcome can consume the value created by shop growth. Excluding restatement costs alone still leaves underlying margin below last year.
Our take: The operating engine is intact, but the bears have the stronger argument on the pace of earnings recovery. Our forecast retains growth while reducing FY26 EPS to $1.15 and allowing residual remediation expense in 2027.
Debate: a near-term capital catalyst or another waiting period?
Bull view: Leverage at 3.1x makes the 3.0x target tangible, potentially opening cash flow to shareholders. A company with profitable new-shop opportunities has several ways to create value.
Bear view: No distribution has been approved, and more internal investment could absorb the cash. The proposal rejection leaves investors reliant on execution of the standalone plan.
Our take: Debt reduction deserves credit now; a distribution deserves credit once its economics are specified. The balance sheet supports the Hold rather than an Underperform, but it does not justify inserting buyback accretion into the forecast.
Debate: is the post-print discount sufficient?
Bull view: At roughly 11.3x our depressed FY26 EPS, even partial remediation-cost savings could make the shares inexpensive on recovered earnings.
Bear view: Restoring earnings is not the same as restoring confidence. A multiple discount can persist if new accounting expenses appear or lower-income pressure starts to spread.
Our take: A $1.35 FY27 earnings case at 10x produces $13.50, close to the current price. A higher multiple would be reasonable with dependable reporting and a defined capital plan, but paying for both improvements before they occur repeats the assumption that proved premature in Q1.
Our Estimates & Valuation
| Item | Prior recap anchor | Our updated assumption | Reason |
|---|---|---|---|
| FY26 revenue | $1.95–2.05B guidance | $2.00B | Q2 sales met expectations |
| FY26 adjusted EBITDA | $430–460M guidance | $430M | Management expects the low end |
| FY26 adjusted EPS | $1.20 guidance midpoint | $1.15 | Reduced earnings cushion |
| Take 5 segment margin | About 34% | About 34% | Q2 34.3%; cost pressure offsets leverage |
| FY26 restatement expense | $35–45M guidance | About $45M | Top end now expected |
| FY27 adjusted EPS | No explicit prior estimate | $1.35 | Partial cost savings plus modest operating growth |
| Capital return | Potential year-end framework | No dividend or buyback assumed | Plan remains conditional on 3.0x |
FY27 earnings bridge: Starting from $1.15 of FY26 EPS, we assume a $30M reduction in restatement expense, $10M of operating profit growth after depreciation, $5M of interest savings and $1M of additional other expense. At an assumed 25% incremental tax rate and 165M diluted shares, the $44M pre-tax improvement contributes $0.20 per share, giving $1.35. The operating increment relies principally on continued Take 5 openings with a roughly 34% segment margin; it does not require a collision rebound. The $15M residual remediation allowance leaves room for a slower cleanup.
Valuation method: We value FY27 adjusted EPS over a 12-month horizon to August 2027. Our 10x base P/E is an analyst judgment reflecting modest underlying profit growth, 3.1x current leverage and unresolved reporting risk, partly offset by the unit runway and high-margin franchise cash flow. It is slightly above the current 9.6x price-to-FY27-estimate ratio, allowing only limited confidence recovery. The prior recap did not publish a numerical target or multiple; this is a new explicit valuation framework.
| 12-month case | FY27 adjusted EPS | P/E assumption | Equity value | Return from $12.96 |
|---|---|---|---|---|
| Bear | $1.05 | 8x | $8.40 | −35.2% |
| Base | $1.35 | 10x | $13.50 | +4.2% |
| Bull | $1.55 | 12x | $18.60 | +43.5% |
The bear case assumes recurring cleanup costs and broader customer weakness offset most of the planned earnings recovery, with a lower multiple for unreliable reporting. The bull case assumes most restatement expense disappears, Take 5 maintains mid-30s margins as its footprint expands, and a credible capital plan restores confidence. The bull value is an operating scenario, not an assumption that the rejected proposal closes.
No dividend is included in these returns, and no share reduction is assumed. Against an illustrative 8% S&P 500 total-return expectation over the same horizon, the 4.2% base return does not justify Outperform. The wide $8.40–18.60 range illustrates the genuine optionality and downside: intact Take 5 demand and the approaching debt target keep us at Hold, while the risk of another earnings reset argues against adding solely because the shares fell.
Thesis Scorecard Post-Earnings
| Standing thesis point | Q2 assessment | Status and consequence |
|---|---|---|
| Bull 1: Take 5 engine | Confirmed on demand; less margin cushion | ON TRACK → ON TRACK. 3.6% comp met expectations; store-cost pressure restrains profit leverage. |
| Bull 2: Deleveraging to 3.0x | Confirmed | ON TRACK → ON TRACK. 3.1x and healthy FCF support the target; it has not yet been reached. |
| Bull 3: Non-oil attachment lever | Confirmed | ON TRACK → ON TRACK. Almost 30% of sales from non-oil services; attachment remains strong. |
| Bull 4: Portfolio simplification | Confirmed | ON TRACK → ON TRACK. Three-segment structure and capital discipline remain; no further sale assumed. |
| Bear 1: Flat consolidated growth | Strengthening | CONTAINED → EMERGING. Low-end FY EBITDA outlook and weaker ex-restatement margin narrow recovery headroom. |
| Bear 2: Franchise-segment drag | Contained | CONTAINED → CONTAINED. Moderation was expected; 59.1% margin sustains the cash role. |
| Bear 3: Leverage / refinancing risk | Contained | CONTAINED → CONTAINED. Leverage declines; interest savings continue, without treating the debt risk as eliminated. |
| Bear 4: Restatement / controls overhang | Strengthening | EMERGING → MATERIALIZING. New historical cleanup and high-end remediation spending reverse last quarter's easing assessment. |
Overall: The operating thesis survives, but the path from growth to dependable shareholder earnings is weaker than the Q1 upgrade assumed. Stable Take 5 cohorts meet the prior demand condition; they do not resolve the renewed accounting risk or commit the cash engine to capital return.
Action: Hold, with conviction reduced to 5/10. An upgrade would require the actual 3.0x leverage milestone and a credible allocation plan, alongside fewer accounting surprises and delivery of Take 5's mid-30s margin framework. Broader cohort weakness, failure to sustain that margin or another reset below the $430M EBITDA low end would warrant reassessment toward Underperform. At $12.96, our $13.50 base value leaves too little expected return to add ahead of those tests.